RETHINK ADHD SYMPTOM CONTROL
Live / Registered — Registered (as of 08 Mar 2022)
What this means for you
Registered since 08 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90287870
- Registration number
- 6668162
- Mark type
- Slogan / phrase
- Filed
- 29 Oct 2020
- Published for opposition
- 18 May 2021
- Registered
- 08 Mar 2022
- Attorney of record
- Mark Simpson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
Owner
- Supernus Pharmaceuticals, Inc., Rockville, MD, US
- Supernus Pharmaceuticals, Inc., Rockville, MD, US
- Supernus Pharmaceuticals, Inc., Rockville, MD, US
Prosecution history
- 08 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 03 Feb 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Feb 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Jan 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Jan 2022 — USE AMENDMENT FILED
- 28 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Jan 2022 — TEAS STATEMENT OF USE RECEIVED
- 13 Jul 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 May 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 May 2021 — PUBLISHED FOR OPPOSITION
- 28 Apr 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Apr 2021 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 30 Mar 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Mar 2021 — ASSIGNED TO EXAMINER
- 22 Dec 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED